Millennium Management’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-13,746
Closed -$26K 4757
2019
Q2
$26K Buy
+13,746
New +$28.1K ﹤0.01% 3973
2016
Q3
Sell
-3,082
Closed -$53K 3774
2016
Q2
$53K Buy
+3,082
New +$96K ﹤0.01% 3073
2016
Q1
Sell
-908
Closed -$62K 3835
2015
Q4
$62K Buy
+908
New +$65.2K ﹤0.01% 3295
2015
Q3
Sell
-1,171
Closed -$93K 3878
2015
Q2
$93K Sell
1,171
-2,555
-69% -$172K ﹤0.01% 3182
2015
Q1
$252K Buy
3,726
+2,662
+250% +$171K ﹤0.01% 3161
2014
Q4
$41K Buy
+1,064
New +$43K ﹤0.01% 3837
2014
Q3
Sell
-945
Closed -$57K 4150
2014
Q2
$57K Buy
+945
New +$52.7K ﹤0.01% 3296

Other funds holding FCSC

Millennium Management's FCSC Position: Q3 2019 in Review

Millennium Management sold out of Fibrocell Science Inc. (FCSC) in Q3 2019, closing a stake of 13,746 shares — an estimated $26K sold.

Millennium Management first reported a position in FCSC in Q2 2014 and held it in 7 quarters. The position peaked at $252K in Q1 2015. 22 funds tracked by Wall St. Rank hold FCSC as of Q3 2019.

  • Millennium Management reported no remaining Fibrocell Science Inc. position as of Q3 2019 after selling out during the quarter.
  • Millennium Management sold 13,746 Fibrocell Science Inc. shares in Q3 2019, an estimated $26K.
  • Millennium Management first reported a position in Fibrocell Science Inc. in Q2 2014 and held it in 7 quarters.
  • Millennium Management's Fibrocell Science Inc. position peaked at $252K in Q1 2015.
  • 22 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2019.

Based on Millennium Management's 13F filing for Q3 2019, filed 14 Nov 2019.